Oncolytic Adenovirus Retargeted to Delta-EGFR Induces Selective Antiglioma Activity

The fact that glioblastomas, which are one of the most devastating cancers, frequently express the Delta EGFR also called mutant variant III of EGFR (EGFRvIII) suggests that this cancer cell–specific receptor might serve as an ideal target for cancer therapy. To assess its potential as such a target...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Piao, Y, Jiang, H, Alemany, R, Krasnykh, V, Marini, FC, Xu, J, Alonso, MM, Conrad, CA, Aldape, Kenneth D., Gomez-Manzano, C, Fueyo, J
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3793894/
https://ncbi.nlm.nih.gov/pubmed/18927600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2008.75
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky